Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.
Journal: BMC neurology
Published: October 29, 2015
Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A.
Journal: Thrombosis and haemostasis
Published: October 07, 2015
Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 05, 2015
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 24, 2014
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Journal: Neurology
Published: June 06, 2014
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study.
Journal: British journal of haematology
Published: May 21, 2014
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.
Journal: The New England journal of medicine
Published: December 06, 2013
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Journal: Blood
Published: November 15, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026